EGFR-HER2 inhibitor Lapatinib ditosylate, Purity ≥98%

Cat. No.: X23-10-ZQ1038

EGFR-HER2 inhibitor Lapatinib ditosylate, Purity ≥98%

Synonym: Lapatinib Ditosylate; 388082-77-7; Tykerb; Tykerb Ditosylate; Lapatinib (ditosylate); Lapatinib (GW-572016) Ditosylate; EGFR-HER2 inhibitor

  • MDL: MFCD09264195
  • CAS Number: 388082-77-7
  • Compound CID: 9941095
Product Size
25 mg; 50 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
Lapatinib ditosylate, soluble in DMSO and insoluble in ethanol and water, is a potent and specific inhibitor of the tyrosine kinase activity of EGFR. It targets EGFR, ErbB4, c-Fms, and C-Raf-1.
Molecular Weight
925.46
Molecular Formula
C43H42ClFN4O10S3
Targets
EGFR: 10.8 nM; ErbB4: 367 nM; c-Fms: >10 μM; C-Raf-1: >10 μM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 93 mg/mL (100.49 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Lapatinib ditosylate can be used to inhibit both EGFR and HER2 (ErbB2) in cancer research.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.